Primary Care Clinics in Elk River, MN Accepting Medicare
8 Primary Care Clinics found. Showing 1 - 8
 M Health Fairview Clinic - Elk River Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 290 Main St Nw, Ste 100, Elk River, MN 55330 Phone: 763-241-5800 Fax: 763-241-5835 |
Fairview Recovery Services Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 1230 School St Nw, Elk River, MN 55330 Phone: 763-241-3558 Fax: 763-241-3540 |
Healing Choices Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 200 5th St Nw, Elk River, MN 55330 Phone: 763-241-5436 |
Allina Health Elk River Clinic Clinic/Center Medicare: Medicare Enrolled Practice Location: 14181 Business Center Dr Nw, Elk River, MN 55330 Phone: 763-236-0500 Fax: 763-236-0565 |
Gangl Chiropractic Inc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 18336 Joplin St Nw, Elk River, MN 55330 Phone: 763-441-0999 Fax: 763-441-3888 |
Elk River Chiropractic,p.a. Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 653 Main St Nw, Elk River, MN 55330 Phone: 763-441-2411 |
North Memorial Health Clinic - Elk River Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 800 Freeport Ave Nw Ste 100, Elk River, MN 55330 Phone: 763-581-2273 Fax: 763-581-5201 |
Collyard Chiropractic P A Clinic/Center Medicare: Medicare Enrolled Practice Location: 510 Freeport Ave Nw Ste F, Elk River, MN 55330 Phone: 763-274-0377 Fax: 763-633-0366 |
News Archive
FDA clears Toshiba's CT Myocardial Perfusion technology
To improve cardiac diagnoses with simplified dose reduction technology, Toshiba announces the FDA clearance of its industry-exclusive CT Myocardial Perfusion capability. Available on Toshiba's AquilionTM ONE and Aquilion ONE ViSION Edition CT systems.
Sensor technology has potential to improve teaching of proper CBE techniques
Sensor technology has the potential to significantly improve the teaching of proper technique for clinical breast exams (CBE), according to a new study by researchers at the University of Wisconsin School of Medicine and Public Health.
White House scrambles for compromise on birth control rule
Officials say Obama remains committed to the HHS regulation, amid indications they are exploring ways to get around religious groups' complaints.
OXiGENE, NCI/CTEP and GOG collaborate on ZYBRESTAT Phase 2 study in relapsed ovarian cancer
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP) to collaborate on the conduct of a randomized Phase 2 trial of ZYBRESTAT in combination with bevacizumab in patients with relapsed ovarian cancer.
› Verified 7 days ago